Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity
暂无分享,去创建一个
[1] M. Chan-yeung,et al. SARS: epidemiology , 2003, Respirology.
[2] Giuseppe Citerio,et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) , 2020, Intensive Care Medicine.
[3] C. Mantzoros,et al. Commentary: COVID-19 in patients with diabetes , 2020, Metabolism.
[4] J. Chan,et al. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS , 2006, Diabetic medicine : a journal of the British Diabetic Association.
[5] David Kerr,et al. Consensus Report: The Current Role of Self-Monitoring of Blood Glucose in Non-Insulin-Treated Type 2 Diabetes , 2011, Journal of diabetes science and technology.
[6] David C. Klonoff,et al. Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital , 2018, Diabetes Care.
[7] Marc A Pfeffer,et al. Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 , 2020, The New England journal of medicine.
[8] SEPSIS BULLETIN,et al. Surviving Sepsis Campaign : Guidelines on the Management of Critically Ill Adults with Coronavirus Disease , 2020 .
[9] J. Hollander,et al. Virtually Perfect? Telemedicine for Covid-19. , 2020, The New England journal of medicine.
[10] Michael Roth,et al. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? , 2020, The Lancet Respiratory Medicine.